- Home
- CANF vs HTOO Comparison
CANF vs HTOO Comparison
Compare CANF & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | HTOO |
|---|---|---|
| Founded | 1994 | 2020 |
| Country | Israel | Ireland |
| Employees | N/A | 131 |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 8.1M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CANF | HTOO |
|---|---|---|
| Price | $3.15 | $2.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9,750.00 | N/A |
| AVG Volume (30 Days) | ★ 37.2K | 26.5K |
| Earning Date | 03-26-2026 | 02-28-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,715,455.50 | $4,832.46 |
| Revenue Next Year | $101.06 | $81.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.15 |
| 52 Week High | $10.40 | $12.63 |
Technical Indicators
Market Signals| Indicator | CANF | HTOO |
|---|---|---|
| Relative Strength Index (RSI) | 36.69 | 42.02 |
| Support Level | $0.59 | $2.41 |
| Resistance Level | $4.74 | $4.26 |
| Average True Range (ATR) | 0.18 | 0.21 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 18.97 | 67.44 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.